Cardiff Oncology
Price & Volume
Stats
See more52W Range | $2.01-$5.63 |
Market Cap | $196.2M |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $683,000 |
Revenue Growth (YoY) | -3.2% |
Gross Profit (12 Mos) | -$36.1M |
Diluted EPS | -$0.97 |
News
See moreYahoo Finance • 15 days ago
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 15 days ago
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Yahoo Finance • 2 months ago
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Yahoo Finance • 2 months ago
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update
About
CEO | Dr. Mark Erlander Ph.D. |
Address | 11055 Flintkote Avenue, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
